Organovo Revenue and Competitors
Estimated Revenue & Valuation
- Organovo's estimated annual revenue is currently $7.5M per year.
- Organovo's estimated revenue per employee is $208,333
- Organovo's total funding is $112.3M.
Employee Data
- Organovo has 36 Employees.
- Organovo grew their employee count by -5% last year.
Organovo's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Research & Development | Reveal Email/Phone |
2 | SVP, Strategy and Business Development | Reveal Email/Phone |
3 | Sr. Director | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Associate Director | Reveal Email/Phone |
6 | Director Drug Discovery | Reveal Email/Phone |
7 | Manager, Financial Reporting | Reveal Email/Phone |
8 | Senior Paralegal | Reveal Email/Phone |
9 | Lead Engineer | Reveal Email/Phone |
10 | Scientist 3 | Reveal Email/Phone |
Organovo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.4M | 126 | -6% | N/A | N/A |
What Is Organovo?
Organovo is a regenerative medicine company focused on delivering breakthrough tissue printing technology and creating tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology platform that works across all tissue types, Organovo is helping physicians and researchers fulfill the promise of regenerative medicine. We aim to overcome critical problems in cardiovascular medicine, medical research, and eventually transplant medicine. Organovo technology leads the way in solving complex medical problems with one overarching goal: to benefit the health and lives of our patients.
keywords:Biotechnology
$112.3M
Total Funding
36
Number of Employees
$7.5M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Organovo News
Organovo Holdings Envisiontec GmbH, Nano 3D Biosciences Cyfuse Biomedical K.K., Regenhu Ltd., Aspect Biosystems Ltd., Biobots, Cellink,...
Comparatively, 2.0% of Organovo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge...
Organovo has a 12-month low of $2.56 and a 12-month high of $11.25. The company has a market cap of $27.77 million, a price-to-earnings ratio of...
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned, without any business being conducted, due to lack of the required qu ...
ORGANOVO ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF SHAREHOLDERS DUE TO LACK OF QUORUM Solana Beach, CA., September 17, 2021-Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company's annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 36 | 9% | N/A |
#2 | $4.2M | 36 | N/A | N/A |
#3 | $8.9M | 36 | N/A | N/A |
#4 | $4.2M | 36 | -3% | N/A |
#5 | $7.5M | 36 | -3% | N/A |